Company intelligence / Profile preview
Oakrum Pharma
St. Louis, Missouri, United Statesoakrumpharma.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Oakrum Pharma commercializes affordable small-molecule generic therapies for rare diseases and specialty indications, including FDA-approved generics such as betaine anhydrous powder (generic of Cystadane) and deferasirox granules (generic of Jadenu Sprinkle). Clinical trial results are not applicable as Oakrum focuses on generics.
- Therapeutic areas
- Rare Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
ANI PharmaceuticalsAucta PharmaSunGen Pharma
Beyond the preview
Go deeper on Oakrum Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oakrum Pharma.